Immuno - oncolocy has been the focus of Big
Pharma and biotechs alike, with
companies such as
Merck (mrk), Bristol - Myers Squibb (bmy), Pfizer (pfe), Roche / Genentech, Juno (juno), Kite
Pharma (kite), Novartis (nvs), and countless others pouring massive investments into the space (the Loncar ETF contains almost all of these
companies).
Ideal
Companies: Any Pharmaceutical, Bio therapeutic, Medical Corporation:, Abbott, Acredo, Acorda, Allergan, Amgen, Amylin, Aptalis, Astellas, Astra Zeneca, Avanir, Aventis, Baxter, Bayer, Becton Dickinson, Biogen Idec, Boehringer Ingelheim, Bristol Myers Squibb, Celgene, Centrix, Covidien, CSL Behring, Daichii Sankyo, Dainippon Sumitomo, Eisai, Eli Lilly, Endo
Pharma, Ferring
Pharma, Forest Laboratories, General Electric, Genentech, Genzyme, Glaxo Smith Kline, Hoffman - LaRoche, Hospira, InVentiv Health, Ironwood
Pharma, Johnson & Johnson, Medicis
Pharma, Medimmune, MedIsolv,
Merck, Medtronic, Mylan Inc., Norgenix, Novis
Pharma, Novo Nordisk, OctaPharma, Onyx
Pharma, Ortho - McNeil, Otsuka
Pharma, PDI, PDL BioPharma, Pfizer, Proctor & Gamble, Publicis, Purdue
Pharma, Purepac
Pharma, Quest Diagnostics, Lab Corps, Quintiles, Ranbaxy
Pharma, Regeneron
Pharma, Respa
Pharma, Roche Phaarma, Royalty
Pharma, Cypress Bioscience, Salix
Pharma, Sanofi - Aventis, Savient
Pharma, Shire
Pharma, Sigfreid USA, Spectrum
Pharma, Stryker Corp, Sunovion
Pharma, Takeda
Pharma, Teva
Pharma, UCB
Pharma, United Therapeutics, Zoetis Animal
Pharma, 3M
Pharma, Actavis
Pharma, Indeva
Pharma, Sunageva BioPharma, Dupont, plus any!